Surgical resection remains the primary treatment for stage I to III tumors, with prognosis influenced by various pathologic, clinical, molecular, and histologic factors, such as histologic grade, tumor–node–metastasis staging, preoperative carcinoembryonic antigen levels, mismatch repair deficiency status, and presence of CDX2 (26–32). Here, CEACAM5 is linked to neoplasm.